<label id="mboud"><meter id="mboud"></meter></label>

        <rt id="mboud"><small id="mboud"><strike id="mboud"></strike></small></rt>
        咨詢熱線

        15000266580

        當前位置:首頁 >產品中心>細胞庫>人腫瘤細胞、癌細胞>CRL-2557Panc 05.04 人胰腺癌細胞

        Panc 05.04 人胰腺癌細胞

        簡要描述:CRL-2557 Panc 05.04 人胰腺癌細胞,
        原代細胞|細胞系|細胞株|菌種;細胞庫管理規范,
        提供的細胞株背景清楚,提供參考文獻和培養條件!

        • 產品型號:CRL-2557
        • 廠商性質:生產廠家
        • 更新時間:2025-04-26
        • 訪  問  量:1984

        產品分類

        Product Category

        詳細介紹

        CRL-2557 Panc 05.04 人胰腺癌細胞

        ATCC® Number: CRL-2557™ Price: $417.00

        Designations: Panc 05.04

        Depositors: EM Jaffee

        Biosafety Level: 1

        Shipped: frozen

        Medium & Serum: See Propagation

        Growth Properties: adherent

        Organism: Homo sapiens (human)

        Morphology: epithelial

        Source: Organ: pancreas

        Disease: adenocarcinoma

        Cellular Products: cytokeratins 7 and 18 [50655]

        Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimay responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.


        CRL-2557 Panc 05.04 人胰腺癌細胞

        Isolation: Isolation date: May 5, 1995

        Tumorigenic: Yes

        Oncogene: K-ras +

        Antigen Expression: MHC class I +; MHC class II - [50655]

        Blood type B; Rh+

        Age: 77 years adult

        Gender: female

        Ethnicity: White

        Comments: Panc 05.04 is a pancreatic adenocarcinoma epithelial cell line derived, in 1995, from a primary tumor removed from the head-of-the-pancreas of a female with pancreatic adenocarcinoma.

        The cell line exhibits a K-ras oncogene mutation at codon 12 where a GGT --> GAT mutation resulted in substitution of aspartic acid for glycine. [50655]

        The cells have a reported plating efficiency of 100%. [50655]

        Propagation: ATCC complete growth medium: RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate and supplemented with 20 Units/ml human recombinant insulin, 85%; fetal bovine serum, 15%

        Atmosphere: air, 95%; carbon dioxide (CO2), 5%

        Temperature: 37.0°C

        Subculturing: Protocol:

        1.Remove and discard culture medium.

        2.Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.

        3.Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).

        Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

        4.Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.

        5.To remove trypsin-EDTA solution, transfer cell suspension to centrifuge tube and spin at approximay 125 xg for 5 to 10 minutes.Discard supernatant and resuspend cells in fresh growth medium. Add appropriate aliquots of cell suspension to new culture vessels.

        6.Incubate cultures at 37°C.

        Subc*tion Ratio: A subc*tion ratio of 1:3 to 1:5 is recommended

        Medium Renewal: Add media once per week. Fluid change one to two times per week.

        Preservation: Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO

        Storage temperature: liquid nitrogen vapor phase

        Doubling Time: 46 hrs

        Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001

        recommended serum:ATCC 30-2020

        References: 50655: Jaffee EM, et al. Development and characterization of a cytokine-secreting pancreatic adenocarcinoma vaccine from primary tumors for use in clinical trials. Cancer J. Sci. Am. 4: 194-203, 1998. PubMed: 9612602

        CRL-2557


















        產品咨詢

        留言框

        • 產品:

        • 您的單位:

        • 您的姓名:

        • 聯系電話:

        • 常用郵箱:

        • 省份:

        • 詳細地址:

        • 補充說明:

        • 驗證碼:

          請輸入計算結果(填寫阿拉伯數字),如:三加四=7
        聯系方式

        郵箱:xiangfbio@163.com

        地址:上海市虹口區四平路710號7層

        咨詢熱線

        400-821-8510

        (周一至周日9:00- 19:00)

        在線咨詢
        • 掃一掃 微信咨詢

        Copyright©2025 上海復祥生物科技有限公司 All Right Reserved    備案號:滬ICP備10013034號-2     sitemap.xml
        技術支持:化工儀器網    管理登陸
        主站蜘蛛池模板: 久99久精品免费视频热77| 最近中文字幕无免费| 亚洲av无码乱码国产精品fc2| 午夜不卡久久精品无码免费 | 成年女性特黄午夜视频免费看 | 在线免费观看伊人三级电影| 久久丫精品国产亚洲av| 精品无码国产污污污免费| 久久久WWW成人免费精品| 亚洲国产成人精品无码一区二区 | 日本最新免费网站| 特级毛片A级毛片免费播放| 麻豆亚洲av熟女国产一区二| 成年女人永久免费观看片| 国产午夜免费高清久久影院| 亚洲日韩AV一区二区三区中文 | 亚洲av无码一区二区三区网站| 一本岛高清v不卡免费一三区| 一级看片免费视频| 亚洲国产最大av| 亚洲日韩激情无码一区| 国产精品麻豆免费版| 最近中文字幕免费mv在线视频| 特级aaaaaaaaa毛片免费视频| 亚洲成人黄色在线观看| 亚洲欧洲美洲无码精品VA| 国产无遮挡吃胸膜奶免费看| 最好看最新的中文字幕免费| 人碰人碰人成人免费视频| 四虎亚洲精品高清在线观看| 亚洲AV无码久久精品色欲| 亚洲一本大道无码av天堂| 成人片黄网站A毛片免费| 伊人久久免费视频| 国产一级a毛一级a看免费视频| 亚洲乱亚洲乱妇24p| 亚洲日本视频在线观看| 国产亚洲成AV人片在线观黄桃| 一本久到久久亚洲综合| 成人免费网站在线观看| 中文字幕影片免费在线观看|